相关实验视频
Updated: Jan 6, 2026

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
10.2K
与补充剂使用相关的心血管毒性
1Department of Emergency Medicine, Division of Medical Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA.
Clinical toxicology (Philadelphia, Pa.)
|September 17, 2025
概括
食补充剂可以通过各种机制引起严重的心脏问题,包括刺激作用,离子通道中毒和内分泌干扰. 意识至关重要,因为这些可以导致危及生命的心血管毒性.
科学领域:
- 心脏病学 心脏病学
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 食补充剂的使用正在增加,有限的FDA监管主要依赖于营销后监测.
- 补充剂由于改,替代或固有的毒性而带来心血管安全风险.
- 补充剂诱导的心血管毒性的机制包括刺激作用,离子通道中毒,心脏活性类固醇和内分泌调节.
研究的目的:
- 审查与食补充剂使用相关的心血管毒性的机制和临床意义.
- 为临床医生提供与补充剂相关的潜在危及生命的心血管事件的信息.
主要方法:
- 关于补充剂诱导心血管毒性的报告病例和机制的文献综述.
- 基于活性补充剂成分及其生理标的毒性作用的分类.
主要成果:
- 中枢神经系统的兴奋剂 (例如,以弗得拉,synephrine) 可以导致心动减速,高血压,心肌梗塞和心脏骤停.
- 心脏离子通道中毒 (例如,阿科尼丁,灰色毒素,柏柏林) 可以导致心律失常,如广泛复杂的心律失常和torsade de pointes.
- 心脏活性类固醇和内分泌调节剂 (例如,黑甘) 可以导致严重的毒性,包括低血和致命的心律失常.
结论:
- 补充剂的心血管毒性,虽然很少见,但可能是严重的和危及生命的.
- 多种机制有助于补充诱导的心脏损伤.
- 临床医生必须对饮食补充剂的潜在心血管中毒保持警.
相关概念视频
Exercise and Cardiovascular Response
3.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Vitamins
2.2K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.2K
Imbalances in Cardiac Output
2.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K
Coronary Artery Disease III: Clinical Manifestations
295
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
295

